Description

The congenital heart defect devices market in USA is poised to grow by US$ 217.4 million during 2022-2028, progressing at a CAGR of 6.3% during the forecast period, according to data and analytics company StrategyHelix.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for congenital heart defect devices. The USA congenital heart defect devices market is segmented on the basis of product. By product, the congenital heart defect devices market in USA has been segmented into pulmonary and cardiovascular patches, pulmonary valve conduits, septal occluders, mechanical mitral valves. According to the research, the pulmonary and cardiovascular patches segment had the largest share in the congenital heart defect devices market in USA.

Key companies profiled in the report include Abbott Laboratories, Edwards Lifesciences Corporation, Medtronic plc, W. L. Gore & Associates Inc. Competitive landscape gives a description of the competitive nature of the congenital heart defect devices market in USA and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the congenital heart defect devices market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Product: pulmonary and cardiovascular patches, pulmonary valve conduits, septal occluders, mechanical mitral valves
Years considered: this report covers the period 2018 to 2028
Company mentioned: Abbott Laboratories, Edwards Lifesciences Corporation, Medtronic plc, W. L. Gore & Associates Inc.

Key Benefits for Stakeholders

– Get a comprehensive picture of the USA congenital heart defect devices market
– Identify regional strategies and strategic priorities on the basis of local data
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Study period
– Geographical scope
– Research methodology
Part 2. Congenital heart defect devices market overview
Part 3. Market breakdown by product
– Pulmonary and cardiovascular patches
– Pulmonary valve conduits
– Septal occluders
– Mechanical mitral valves
Part 4. Key companies
– Abbott Laboratories
– Edwards Lifesciences Corporation
– Medtronic plc
– W. L. Gore & Associates, Inc.
About StrategyHelix
Disclaimer